摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(β-D-glucopyranos-1-yl)-1-methoxy-4-(4-ethynyl-benzyl)-benzene | 892486-52-1

中文名称
——
中文别名
——
英文名称
2-(β-D-glucopyranos-1-yl)-1-methoxy-4-(4-ethynyl-benzyl)-benzene
英文别名
(2S,3R,4R,5S,6R)-2-[5-[(4-ethynylphenyl)methyl]-2-methoxyphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
2-(β-D-glucopyranos-1-yl)-1-methoxy-4-(4-ethynyl-benzyl)-benzene化学式
CAS
892486-52-1
化学式
C22H24O6
mdl
——
分子量
384.429
InChiKey
NODISAXAEMWZSW-BDHVOXNPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    596.7±50.0 °C(Predicted)
  • 密度:
    1.35±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    28
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    99.4
  • 氢给体数:
    4
  • 氢受体数:
    6

文献信息

  • Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
    申请人:Himmelsbach Frank
    公开号:US20060189548A1
    公开(公告)日:2006-08-24
    Glucopyranosyl-substituted (hetero)arylethynyl-benzene derivatives of the general formula I where the groups R 1 to R 6 as well as R 7a , R 7b , R 7c are defined according to claim 1 , including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
    通用公式I的葡萄糖喃基取代的(杂)芳基乙炔基苯衍生物,其中基团R1至R6以及R7a、R7b、R7c根据权利要求1定义,包括其互变异构体、立体异构体、混合物及其盐。本发明的化合物适用于治疗代谢紊乱。
  • Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
    申请人:Himmelsbach Frank
    公开号:US20070027092A1
    公开(公告)日:2007-02-01
    Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives of the general formula I where the groups R 1 to R 6 as well as R 7a , R 7b , R 7c are defined according to claim 1 , including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
    通用式I的葡萄糖喃基取代的((杂)环烷基乙炔基苄基)苯衍生物,其中基团R1至R6以及R7a、R7b、R7c根据权利要求1定义,包括其互变异构体、立体异构体、混合物及其盐。本发明的化合物适用于治疗代谢紊乱。
  • GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE
    申请人:ECKHARDT Matthias
    公开号:US20120296080A1
    公开(公告)日:2012-11-22
    Glucopyranosyl-substituted benzene derivatives of general formula I where the groups R 1 to R 6 as well as R 7a , R 7b , R 7c are defined herein and the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
    本发明涉及一般式I的葡萄糖喃糖苷取代苯衍生物,其中所述基团R1至R6以及R7a、R7b、R7c的定义如本文所述,以及其互变异构体、立体异构体、混合物和盐。本发明的化合物适用于治疗代谢紊乱。
  • GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE
    申请人:ECKHARDT Matthias
    公开号:US20140046046A1
    公开(公告)日:2014-02-13
    Glucopyranosyl-substituted benzene derivatives of general formula I where the groups R 1 to R 6 as well as R 7a , R 7b , R 7c are defined herein and the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
    本发明提供了一般式I的葡萄糖喃取代苯衍生物,其中基团R1至R6以及R7a、R7b、R7c在此定义,以及其互变异构体、立体异构体、混合物和盐。本发明的化合物适用于治疗代谢紊乱。
  • Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
    申请人:Eckhardt Matthias
    公开号:US20060142210A1
    公开(公告)日:2006-06-29
    Glucopyranosyl-substituted benzene derivatives defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
    根据权利要求1定义的葡萄糖喃基取代的苯衍生物,包括其互变异构体、立体异构体、混合物和盐。本发明的化合物适用于治疗代谢性疾病。
查看更多